COPD Exacerbation Acute: Clinical Trials

3 trials for COPD Exacerbation Acute, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Recruiting 1, Unknown 1

Follow COPD Exacerbation Acute: new trials by email Literature Review of COPD Exacerbation Acute trials Research Report on COPD Exacerbation Acute

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease
Titrated Oxygen, Standard Oxygen - COPD Exacerbation, COPD Exacerbation Acute
Phase 4RecruitingCentral Denmark Region18882025-06-022026-10-02
A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Sitafloxacin, Moxifloxacin Hydrochloride - COPD Exacerbation Acute
Phase 4CompletedDaiichi Sankyo1402022-08-102025-01-09
Prednisone Reduction in ICU Patients With COPD Exacerbation
Prednisone - Copd Exacerbation Acute, Mechanical Ventilation
Phase 4UnknownHôpital Universitaire Fattouma Bourguiba1922019-04-022019-06-10

Narrower conditions

Pulmonary Disease, Chronic Obstructive (3)  ·  Respiratory Insufficiency (1)

Broader conditions

Chronic Disease (3)  ·  Disease Attributes (3)  ·  Lung Diseases (3)  ·  Lung Diseases, Obstructive (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Respiratory Tract Diseases (3)  ·  Respiration Disorders (1)

Interventions

Moxifloxacin (1)  ·  Prednisone (1)  ·  sitafloxacin (1)

Sponsors

Central Denmark Region (1)  ·  Daiichi Sankyo (1)  ·  Hôpital Universitaire Fattouma Bourguiba (1)

Countries

China (1)  ·  Denmark (1)  ·  Morocco (1)  ·  Tunisia (1)

Top investigators

Martin F Gude, PhD (1)

Results publications

PMID 38273393